Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology

Intensive Care Medicine

Volumn 38, Issue 1, 2012, Pages 105-112

  Tzanetos, Deanna R Todd ^a   Yu, Chang ^b   Hernanz Schulman, Marta ^c   Barr, Frederick E ^d   Brown, Nancy J ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood coagulation tests; Cardiac surgical procedures adverse effects; Congenital surgery; Heart defects; Postoperative complications mortality; Thrombosis epidemiology; Thrombosis etiology

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; CD40 LIGAND; D DIMER; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX; THROMBOXANE B2; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; BIOLOGICAL MARKER;

AORTA CLAMPING; ARTICLE; BLALOCK TAUSSIG SHUNT; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CENTRAL VENOUS CATHETER; CHEST TUBE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRECIPITATE; ECHOCARDIOGRAPHY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FEMORAL VEIN THROMBOSIS; FONTAN PROCEDURE; GLENN SHUNT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEART VENTRICLE FUNCTION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INOTROPE SCORE; INOTROPISM; INTENSIVE CARE UNIT; INTRAVASCULAR ULTRASOUND; LENGTH OF STAY; MALE; NEWBORN; NORWOOD PROCEDURE; PALLIATIVE THERAPY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; THROMBUS; TRICUSPID VALVE ATRESIA; VEIN EMBOLISM; BLOOD; CENTRAL NERVOUS SYSTEM; CONGENITAL HEART MALFORMATION; ECHOGRAPHY; HEART VENTRICLE; HOSPITAL; MEDICAL AUDIT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; THROMBOSIS; UNITED STATES; URINE;

BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL AUDIT; PALLIATIVE CARE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TENNESSEE; THROMBOSIS;

EID: 84859910128     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2378-y     Document Type: Article

References (26)

1. Monagle P (2005) Thrombosis in children with BT shunts, Glenns, and Fontans. Prog Pediatr Cardiol 21:17-21
2. Petaja J, Lundstrom U, Sairanen H, Marttinen E, Griffin J (1996) Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg 112:883-889
3. Fenton K, Siewers R, Rebovich B, Pigula F (2003) Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 76:152-156
4. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P et al (2008) Antithrombotic therapy in neonates and children: American College of Chest Physicians evidencebased clinical practice guidelines (8th edition). Chest 133:887S-968S
5. Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J et al (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85:61-65
6. Cromme-Dijkhuis AH, Henkens CMA, Bijleveld CMA, Hillege HL, Bom VJJ, Van der Meer J (2001) Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 336:1087-1090
7. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E (1997) Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 113:989-992
8. Odegard KC, McGowan FX Jr., Zurakowski D, DiNardo JA, Castro RA, del Nido PJ et al (2002) Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 73:1770-1777
9. Odegard KC, McGowan FX Jr., Zurakowski D, DiNardo JA, Castro RA, del Nido PJ (2002) Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 125:1260-1267
10. Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE (1995) Thromboembolic complications after Fontan operations. Circulation 92:287-293
11. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL (2001) Thrombus formation after the Fontan operation. Ann Thorac Surg 71:1990-1994
12. Monagle P, Andrew M (1998) Coagulation abnormalities after Fontan. J Thorac Cardiovasc Surg 115:732-733
13. Cholette JM, Rubenstein JS, Alfieris GM, McDermott MP, Harmon WG, Vermilion R et al (2007) Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 84:1320-1325
14. Agarwal HS, Churchwell KB, Doyle TP, Christian KG, Drinkwater DC Jr., Byrne DW et al (2006) Inhaled nitric oxide use in bidirectional Glenn anastomosis for elevated Glenn pressures. Ann Thorac Surg 81:1429-1434
15. Morrow JD, Minton TA (1993) Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. J Chromatogr 612:79-85
16. Nowak-Gottl U, Kotthoff S, Hagemeyer E, Junker R, Kehl HG, Vielhaber H, Kececioglu D (2001) Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. A prospective study. Thromb Res 103:93-101
17. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, de Faire U (2000) Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 20:2019-2023
18. Geppert A, Graf S, Beckmann R, Hornykewycz S, Schuster E, Binder B et al (1998) Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler Thromb Vasc Biol 18:1634-1642
19. Chandler WL, Alessi MC, Aillaud MF, Henderson P, Vague P, Juhan-Vague I (1997) Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation 96:761-768
20. Odegard KC, Zurakowski D, DiNardo JA, Castro RA, McGowan FX, Neufeld EJ et al (2009) Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg 137:934-941
21. Hasaniya NW, Razzouk AJ, Mulla NF, Larsen RL, Bailey LL (2010) In situ pericardial extracardiac lateral tunnel Fontan operation: fifteen-year experience. J Thorac Cardiovasc Surg 140:1076-1083
22. Jahangiri M, Kreutzer J, Zurakowski D, Bacha E, Jonas RA (2000) Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 120:778-782
23. Cheung EWY, Chay GW, Ma ESK, Cheung YF (2005) Systemic oxygen saturation and coagulation factor abnormalities before and after the Fontan procedure. Am J Cardiol 96:1571-1575
24. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JGP, Mulder BJM (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82:40-46
25. Procelewska M, Kolcz J, Januszewska K, Mroczek T, Malec E (2007) Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures-the importance of hemodynamics in the early postoperative period. Eur J Cardiothorac Surg 31:866-872
26. Heying R, van Oeveren W, Wilhelm S, Schumacher K, Grabitz RG, Messmer BJ et al (2006) Children undergoing cardiac surgery for complex cardiac defects show imbalance between proand anti-thrombotic activity. Crit Care 10:R165